Pancreatic cystic neoplasms (PCN) are critical precursors for early pancreatic cancer detection, yet current diagnostic methods lack accuracy and consistency. This multicenter study developed and validated an artificial intelligence (AI)-powered CT model (PCN-AI) for…
Continue Reading
Pancreatic cancer (PC) is often diagnosed late, as early symptoms and effective screening tools are lacking, and genetic or familial factors explain only ~10% of cases. Leveraging longitudinal electronic health record (EHR) data may…
Continue Reading
Subspecialty knowledge barriers have limited the adoption of large language models (LLMs) in oncology. We introduce Woollie, an open-source, oncology-specific LLM trained on real-world data from Memorial Sloan Kettering Cancer Center (MSK) across lung,…
Continue Reading
National Taiwan University Hospital has recently launched a new AI-powered diagnostic imaging service for pancreatic cancer.Offered as a self-pay service at the NTUH Department of Medical Imaging since late 2024, it features an AI…
Continue Reading
Revolutionary HIFU Technology Shows Promise
EDAP TMS SA, a leading provider of robotic energy-based therapies, has achieved a significant milestone in pancreatic cancer treatment. The company recently announced the successful treatment of their first patient…
The charity Pancreatic Cancer UK has launched an online tool for families who have lost a loved one to pancreatic cancer to assess their risk of inheriting the disease.
Supported by NHS England, the family…
The RSNA Margulis Award-winning study introduces a game-changing AI-driven tool for pancreatic cancer detection on CT scans. Led by Po-Ting Chen, M.D., and the team, the research showcases the tool’s 90% sensitivity and 93%…
Continue Reading
By Anuja Vaidya
November 02, 2023 – Researchers at the University of Virginia Health (UVA Health) have found that wearable devices can be used to glean insights into patients’ cortisol levels, enabling clinicians to identify and…
Continue Reading
A new pancreatic cancer prediction model, utilizing routine blood markers, may reduce unnecessary biopsies by up to 6%. Researchers have validated this model, which assesses early-stage pancreatic cancer risk, and found it outperforms individual…
Continue Reading
By Shania Kennedy
September 13, 2023 – Researchers have developed and externally validated a prediction model to detect early-stage pancreatic cancer using routinely collected blood biomarkers, according to a recent study published in JAMA Network Open.
The…
